An underground economy for unlicensed slimming medications is being driven by social media fitness personalities and vendors on communication apps, based on recent findings.
Experimental Drug Acquiring Popularity Via Social Media
Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Followers are urged to message these accounts directly for source information, while also obtaining promotional offers.
Thriving Commerce on Social Networks
Additionally, a flourishing market exists on Telegram, where communities with thousands of members share comparison images, administration instructions and claims of rapid British shipping. Vendors promote the substance there before directing customers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
Medical Professionals Voice Concerns
However, doctors and pharmacists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to users administering products of unknown origin.
Some professionals said the demand for retatrutide could be linked to the increasing cost of approved slimming products such as Mounjaro.
Legal Position and Enforcement
Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate pharmaceutical, advertising, and consumer laws, potentially leading to fines, legal action or prison.
Service Reaction and Material Elimination
According to TikTok, the service has taken down violative material and banned associated keywords and query recommendations. The company said it was dedicated to maintaining the platform secure and allocating resources in strengthening enforcement strategies.
Digital Marketplace Operations
Investigations also discovered communities with up to nine thousand participants marketing the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays groups with numerous of users, populated with images of slimming results, glowing reviews and step-by-step instructions for preparing or administering at home.
Within minutes of joining one community, a seller posted WhatsApp details, where most purchases take place. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about weight, health issues or past usage.
Item Information and Pricing
Inside these communities, messages show black plastic parcels with Royal Mail labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with sterile water, or ready-to-use injectors typically priced at £160 for 20 milligrams. When questioned how long a injector should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Actions
A representative for the messaging service said it actively moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting substances they can’t verify. Even if the research behind retatrutide is sound, these online products may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the increase in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.
Her team has already encountered individuals harmed by personal administration from unverified suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, adding that any item “falsely representing itself as a company investigational substance not yet approved … may subject patients to possibly significant medical dangers”.
